PARVULET
LIVE

Serial Number

88667306

Owner

ADARE PHARMACEUTICALS, INC

Attorney

Shawn Duckworth

Filing Date

Oct 24, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PARVULET Trademark

Serial Number: 88667306 • Registration: 6269377

PARVULET is a trademark filed by ADARE PHARMACEUTICALS, INC on October 24, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ADARE PHARMACEUTICALS, INC

7722 Dungan Road
Philadelphia, PA 19111

Entity Type: 03

Trademark Details

Filing Date

October 24, 2019

Registration Date

February 16, 2021

Published for Opposition

December 1, 2020

Goods & Services

Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials for others

Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, fever management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, inflammation, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, disbiosys, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes, namely, for the treatment of illnesses characterized by lack of such peptides and analogues thereof; vitamins; biologics being biopharmaceuticals and biologically active substances for the treatment of exocrine pancreatic insufficiency, cystic fibrosis; pharmaceutical and nutraceuticals preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral powder, oral liquids, oral suspensions, oral gels, and oral emulsions for the immediate or controlled, extended, delayed, pulsatile, local release release of a wide variety of therapeutic agents within a certain time after ingestion; oral powder for reconstitution, namely for immediate or controlled, extended, delayed, pulsatile, local release of a wide variety of therapeutic agents within a certain time after ingestion; medical gel; medicated candy; medicated chewing gum; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds and nutraceuticals; drug delivery systems comprising polymer-based oral tablets, oral powder for immediate or controlled, extended, delayed, pulsatile, local release of a wide variety of therapeutic agents; drug delivery agents for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, powder, emulsions; drug delivery powder for reconstitution in water before administration

Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers in the nature of blister packs and sachets for various pharmaceuticals, drugs, medicines, compounds and substances sold without medication; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems, namely, drug delivery patches sold without medication, implantable drug delivery ports, intravenous bags sold empty for intravenous therapy

Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, fever management, inflammation, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, disbiosys diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research, design and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates and biologics; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines with improved compliance and acceptability by the patients; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like, gelling and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing solid dosage forms such as pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs and biologics; biochemical and molecular biological analyses of pharmaceuticals and nutraceuticals preparations to ensure efficacy and safety; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides or other biologics analogues for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs; preparation of materials for promotional documents and campaigns

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 16, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 20, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2025 COAR
REGISTERED-PRINCIPAL REGISTER
Feb 16, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 11, 2020 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Oct 26, 2020 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 23, 2020 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 23, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 23, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2020 CRFA
ASSIGNED TO LIE
Jul 2, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2019 NWOS
NEW APPLICATION ENTERED
Oct 28, 2019 NWAP